Hemodynamic and Cardiac Effects of Nisoldipine in Ischemic Left Ventricular Dysfunction

Conference paper


The use of calcium antagonists in patients with left ventricular dysfunction remains a controversial issue, largely because of evidence of reflex neurohormonal activation and of worsening of congestive heart failure symptoms during their administration [1–5]. However, the negative results observed with some calcium antagonists such as nifedipine or diltiazem [4, 5] are balanced by more promising observations with amlodipine and nisoldipine [6, 7]. In these studies, the calcium antagonists were well tolerated and there was evidence of an improvement in left ventricular ejection fraction or diastolic filling as well as in exercise capacity.


Myocardial Perfusion Calcium Antagonist Peak Filling Rate Single Photon Emission Compute Tomography Data MIBI Uptake 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Packer M, Lee WH, Medina N, Yushak M, Berstein JL, Kessler PD (1987) Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction. J Am Coll Cardiol 10: 1303–1311PubMedCrossRefGoogle Scholar
  2. 2.
    Packer M (1989) Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure. Circulation 80: 59–67Google Scholar
  3. 3.
    Barjon JN, Rouleau JL, Bichet D, Juneau C, De Champlain J (1987) Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. J Am Coll Cardiol 9: 622–630PubMedCrossRefGoogle Scholar
  4. 4.
    Elkayam U, Amin J, Mehra A, Vasquez J, Weber L, Rahimtoola SH (1990) A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 82: 1954–1961PubMedCrossRefGoogle Scholar
  5. 5.
    Goldstein RD, Boccuzzi SJ, Cruess D, Nattel S (1991) The Adverse Experience Committee and the Multicenter Diltiazem Post-infarction Research Group. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 83: 52–60PubMedGoogle Scholar
  6. 6.
    Packer M, Nicod P, Khandheria BR et al (1991) Randomized, multicentre, double-blind, placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure (abs). J Am Coll Cardiol 17: 274AGoogle Scholar
  7. 7.
    The DEFIANT Research Group (1992) Improved diastolic function with the calcium antagonist nisoldipine (coat-core) in patients post myocardial infarction: results of the DEFIANT study. Eur Heart J 13: 1496–1505Google Scholar
  8. 8.
    Packer M, O’Connor C, Ghali J et al (1996) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 335: 1107–1114PubMedCrossRefGoogle Scholar
  9. 9.
    The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 325: 293–302CrossRefGoogle Scholar
  10. 10.
    The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 327: 685–691CrossRefGoogle Scholar
  11. 11.
    Pfeffer MA, Braunwald E, Moyé LA et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327: 669–677PubMedCrossRefGoogle Scholar
  12. 12.
    Leung W-H, Lau C-P (1992) Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. J Am Coll Cardiol 20: 307–313PubMedCrossRefGoogle Scholar
  13. 13.
    Braunwald E, Rutherford JD (1986) Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”. J Am Coll Cardiol 8: 1467–1470PubMedCrossRefGoogle Scholar
  14. 14.
    Lorell BH, Grossman W (1987) Cardiac hypertrophy: consequences for diastole. J Am Coll Cardiol 9: 1189–1193PubMedCrossRefGoogle Scholar
  15. 15.
    Rousseau MF, Vincent MF, Van Hoof F, Van den Berghe G, Charlier AA, Pouleur H (1984) Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. Am J Cardiol 54: 1189–1194PubMedCrossRefGoogle Scholar
  16. 16.
    Rousseau MF, Hanet C, Desager JP, Pouleur H (1987) Effects of long-term therapy with the association of nisoldipine and a beta-blocker on exercise tolerance and coronary hemodynamics in patients with stable angina: a comparison with mono-therapy. In: Hugenholtz PG, Meyer J (eds) Nisoldipine 1987. Springer, Berlin Heidelberg New York, pp 213–222Google Scholar
  17. 17.
    Frishman WH, Skolnick AE, Strom JA (1989) Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy. Circulation 80: 151–161Google Scholar
  18. 18.
    Rousseau MF, Gurné O, Benedict CR, van Eyll C, Pouleur H (1990) Effects of nisoldipine on the time-dependent changes in left ventricular function and neuro-humoral status in patients with ischemic heart disease. In: Lichtlen PR, Krayenbühl HP (eds) Aspects of nisoldipine. Symposium, 11th Congr European Society of Cardiology, Nice. Schattauer, Stuttgart, pp 69–83Google Scholar
  19. 19.
    Pouleur H, Rousseau MF (1988) Regional diastolic dysfunction in coronary artery disease: clinical and therapeutic implications. In: Grossman W, Lorell BH (eds) Diastolic relaxation of the heart. Martinus Nijhoff, Boston, pp 245–254Google Scholar
  20. 20.
    Pouleur H, van Eyll C, Gurné O, Rousseau MF (1992) Analysis of the mechanisms underlying the changes in left ventricular filling dynamics during oral nisoldipine therapy in patients with anterior myocardial infarction. Eur Heart J 13: 952–959PubMedGoogle Scholar
  21. 21.
    Pouleur H, Rousseau MF, van Eyll C, Charlier AA (1984) Assessment of regional left ventricular relaxation in patients with coronary artery disease: importance of geometric factors and changes in wall thickness. Circulation 69: 696–702PubMedCrossRefGoogle Scholar
  22. 22.
    Gelberg HJ, Brundage BH, Glantz S, Parmley WW (1979) Quantitative left ventricular wall motion analysis: a comparison of area, chord and radial methods. Circulation 59: 991–1000PubMedGoogle Scholar
  23. 23.
    Bonow RO (1990) Regional left ventricular nonuniformity. Effects on left ventricular diastolic function in ischemic heart disease, hypertrophic cardiomyopathy, and the normal heart. Circulation 81: 54–65Google Scholar
  24. 24.
    Kumada T, Karliner J, Pouleur H, Gallagher KP, Shirato K, Ross J Jr (1979) Effects of acute coronary occlusion on early ventricular diastolic events in conscious dogs. Am J Physiol 237: H542 - H549PubMedGoogle Scholar
  25. 25.
    Rousseau MF, Melin J, Benedict CR, Ahn S, Raphaël D, Bornemann M, Pouleur H (1994) Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction. Eur Heart J 15: 957–964PubMedGoogle Scholar
  26. 26.
    Brunelli C, Parodi O, Sambuceti G, Corsiglia L, Rosa GM, Giorgetti A, Bezante GP, Nista N, Caponnetto S (1995) Perfusional and metabolic effects of nisoldipine as shown by positron emission tomography after acute myocardial infarction. Am J Cardiol 75: 31–5ECrossRefGoogle Scholar
  27. 27.
    Lichtlen PR, Hugenholtz PG, Raffenbeul W et al (1990) Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet 335: 1109–1113PubMedCrossRefGoogle Scholar
  28. 28.
    Waters D, Lespérance J, Francetich M et al (1990) A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 82: 1940–1953PubMedCrossRefGoogle Scholar
  29. 29.
    Etingin OR, Hajjar DP (1990) Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue. Clin Res 66: 185–190Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

There are no affiliations available

Personalised recommendations